Lilly's stock rallies as sales of GLP-1 drugs nearly double
礼来礼来(US:LLY) MarketWatch·2026-04-30 18:58

核心观点 - 礼来公司的Mounjaro和Zepbound两款药物的销售额均超出市场预期 [1] 产品表现 - Mounjaro的销售额超出市场预期 [1] - Zepbound的销售额超出市场预期 [1]

Lilly's stock rallies as sales of GLP-1 drugs nearly double - Reportify